Keenova Therapeutics plc Stock Deutsche Boerse AG

Mallinckrodt plc is a global specialty pharmaceutical company consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The Company operates through two segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Company's Specialty Brands segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, and gastrointestinal products. Its Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients (APIs). Its product portfolio includes Acthar Gel, INOmax, StrataGraft, Terlivaz, and Amitiza.